These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24440429)

  • 1. Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.
    Barker CI; Germovsek E; Hoare RL; Lestner JM; Lewis J; Standing JF
    Adv Drug Deliv Rev; 2014 Jun; 73(100):127-39. PubMed ID: 24440429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.
    Chan PL; Jacqmin P; Lavielle M; McFadyen L; Weatherley B
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):41-61. PubMed ID: 21088872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations.
    Brill MJE; Kristoffersson AN; Zhao C; Nielsen EI; Friberg LE
    Clin Microbiol Infect; 2018 Jul; 24(7):697-706. PubMed ID: 29229429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC, pharmacodynamic indices and beyond.
    Rao GG; Landersdorfer CB
    Int J Antimicrob Agents; 2021 Aug; 58(2):106368. PubMed ID: 34058336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.
    Admiraal R; van Kesteren C; Boelens JJ; Bredius RG; Tibboel D; Knibbe CA
    Arch Dis Child; 2014 Mar; 99(3):267-72. PubMed ID: 24356807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.
    Bulik CC; Bader JC; Zhang L; Van Wart SA; Rubino CM; Bhavnani SM; Sweeney KL; Ambrose PG
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):161-177. PubMed ID: 28353185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients.
    Al-Sallami H; Newall F; Monagle P; Ignjatovic V; Cranswick N; Duffull S
    Br J Clin Pharmacol; 2016 Jul; 82(1):178-84. PubMed ID: 26972703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
    Rayner CR; Smith PF; Andes D; Andrews K; Derendorf H; Friberg LE; Hanna D; Lepak A; Mills E; Polasek TM; Roberts JA; Schuck V; Shelton MJ; Wesche D; Rowland-Yeo K
    Clin Pharmacol Ther; 2021 Apr; 109(4):867-891. PubMed ID: 33555032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of antimicrobial drugs.
    Czock D; Markert C; Hartman B; Keller F
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):475-87. PubMed ID: 19416084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic and pharmacodynamic modelling in paediatric drug development with a focus on physiology-based pharmacokinetic simulations].
    Läer S
    Z Evid Fortbild Qual Gesundhwes; 2019 May; 141-142():66-73. PubMed ID: 30935788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs.
    Mouton JW; Dudley MN; Cars O; Derendorf H; Drusano GL
    Int J Antimicrob Agents; 2002 Apr; 19(4):355-8. PubMed ID: 11978507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and applying pharmacometric modelling and simulation in clinical practice and research.
    Standing JF
    Br J Clin Pharmacol; 2017 Feb; 83(2):247-254. PubMed ID: 27567102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation.
    Morse JD; Hannam J; Anderson BJ
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):353-362. PubMed ID: 31045640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of population PK-PD modelling in paediatric clinical research.
    De Cock RF; Piana C; Krekels EH; Danhof M; Allegaert K; Knibbe CA
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1(Suppl 1):5-16. PubMed ID: 20340012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAPPS (Grading and Assessment of Pharmacokinetic-Pharmacodynamic Studies) a critical appraisal system for antimicrobial PKPD studies - development and application in pediatric antibiotic studies.
    Gastine S; Rashed AN; Hsia Y; Jackson C; Barker CIS; Mathur S; Tomlin S; Lutsar I; Bielicki J; Standing JF; Sharland M
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1091-1098. PubMed ID: 31747323
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.
    Mouton JW; Dudley MN; Cars O; Derendorf H; Drusano GL
    J Antimicrob Chemother; 2005 May; 55(5):601-7. PubMed ID: 15772142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic models for time courses of antibiotic effects.
    Minichmayr IK; Aranzana-Climent V; Friberg LE
    Int J Antimicrob Agents; 2022 Sep; 60(3):106616. PubMed ID: 35691605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioning.
    Solans BP; Chiesa R; Doncheva B; Prunty H; Veys P; Trocóniz IF; Standing JF
    Br J Clin Pharmacol; 2020 Aug; 86(8):1537-1549. PubMed ID: 32077123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.